During virus assembly, HIV-1 Gag-Pol is packaged into virions via interaction with Pr55gag. Studies suggest that Gag-Pol by itself is incapable of virus particle assembly or cell release, perhaps due to the lack of a budding domain in the form of p6gag, which is truncated within Gag-Pol because of a ribosomal frameshift during Gag translation. Additionally (or alternatively), large molecular size may not support Gag-Pol assembly into virus-like particles (VLPs) or release from cells. To test these hypotheses, we constructed Gag-Pol expression vectors retaining and lacking p6gag, and then reduced Gag-Pol molecular size by removing various lengths of the Pol sequence. Results indicate that Gag-Pol constructs retaining p6gag were capable of forming VLPs with a WT HIV-1 particle density. Gag-Pol molecular size reduction via partial removal of the Pol sequence mitigated the Gag-Pol assembly defect to a moderate degree. Our results suggest that the Gag-Pol assembly and budding defects are largely due to a lack of p6gag, but also in part due to size limitation.
INTRODUCTION
In the late stages of HIV-1 replication, the Pr55gag viral structure protein precursor is cleaved by viral protease (PR) into four major products: matrix (MA, p17), capsid (CA, p24), nucleocapsid (NC, p7) , and the C-terminal p6 domain (Swanstrom & Wills, 1997) . PR and transcriptase (RT) and integrase (IN) viral enzymes are encoded by pol, which is initially expressed as a Pr160gag-pol polyprotein via a ribosomal frameshift that takes place during gag translation (Jacks et al., 1988) . This gag-pol frameshift, which occurs at a frequency of approximately 5 %, produces a Pr160gag-pol/Pr55gag expression ratio of approximately 1 : 20. Owing to a partial overlap of the gag and pol reading frames, p6 within Pr160gag-pol is truncated and replaced with a transframe (TF) domain referred to as p6 * or p6pol. During or soon after virus budding, PR is activated to cleave Pr55gag and Pr160gag-pol into their respective subcomponents. The virus maturation process consisting of PR-mediated Gag and Gag-Pol precursor cleavage is essential for the requisition of viral infectivity (Göttlinger et al., 1989; Kaplan et al., 1993; Kohl et al., 1988; Peng et al., 1989; Pettit et al., 1994) .
HIV-1 usurps a host cell's endosomal sorting complex required for transport (ESCRT), thus mediating virus budding (Balasubramaniam & Freed, 2011) . p6gag contains two late domains, PT/SAP and YPXL, which in combination are capable of recruiting ESCRT. Accordingly, lack of p6gag is considered a restricting factor to HIV-1 Gag-Pol release, which is apparently dependent on associations with Pr55gag (Chiu et al., 2002; Smith et al., 1993; Srinivasakumar et al., 1995) . may counteract the promoting effect of p6gag on GagPR release. However, in a separate study using an insect cell system, p6gag within PR-inactivated Gag-Pol (similar to the Gag(p6)Pol construct) was observed as markedly reducing VLP yields, as well as quantities of VLP-associated Gag-Pol (Royer et al., 1997) . Royer et al. therefore suggest that p6gag within Gag-Pol exerts a negative impact on VLP production in addition to impeding Gag(p6)Pol viral incorporation.
The purposes of this study are to clarify (a) whether p6gag confers Gag-Pol release capability and (b) whether the Pol domain exerts any negative effect on Gag-Pol assembly and release. Toward this end, we created two sets of Gag-Pol expression plasmids, one with and one without p6gag. Various sequence deletions in the Pol domain were also inserted into Gag-Pol expression vectors. Results indicate that Gag-Pol constructs containing p6gag were released from cells at higher levels compared with their p6gag-lacking counterparts. Further, the stepwise reduction of Gag-Pol size via various Pol sequence deletions resulted in increased Gag-Pol release efficiency; however, this effect was less noticeable in the absence of p6gag.
RESULTS p6gag gives Gag-Pol the ability to form VLPs
To determine if the inability of HIV-1 Gag-Pol to be released from cells is due to a lack of p6gag, we constructed a series of Gag-Pol expression vectors by inserting pol at the end of the gag coding sequence. As shown in Fig. 1(a) , Gagp6-Pol, Gagp6-PR and Gagp6-RT, respectively, contain full-length Pol, a deleted TF, and a deleted TF plus PR. GPfsd (a Gagp6-Pol counterpart lacking p6gag) has gag and pol positioned in the same reading frame owing to a frameshift mutation at the gag/pol junction (Chiu et al., 2002) . D25 (containing an Asn substitution for the PR catalytic Asp residue), which expresses both Pr55gag and Pr160gag-pol, served as a control. To prevent PR activity from impacting VLP assembly and budding, the PR-inactivated D25 mutation was introduced into all Gag-Pol constructs. Data for transient expression in 293T cells indicate that all of the constructs containing p6gag were readily detected in medium; in contrast, GPfsd was barely detected in medium (Fig. 1b , upper panel, lanes 3-5 versus lane 2). This suggests that p6gag confers GagPol release capability. Faint but readily detected bands corresponding to truncated MA-CA-NC-Pol migrated to the 55 kDa position [marked with asterisks in Fig. 1(b, c) and referred to as Pr55gag variants]. The Pr55gag variant likely results from translation termination at a stop codon near the p6gag/Pol junction following ribosomal frameshifts to the pol reading frame during Gag translation.
Consistent with this finding, Pr55gag variant expression was between 10-and 20-fold less than that of p6gag-containing Gag-Pol (Fig. 1b, c, lower panels, lanes 3-5) . This is the reverse of results showing between 10-and 20-fold more Pr55gag than Pr160gag-pol (Fig. 1b, lane 1 and Fig. 1c, lane 2) . Any incorporation of p6gag-containing Gag-Pol into Pr55gag variant particles was minimal, since the quantity of released Pr55gag variants was much less than that of p6gag-containing Gag-Pol. To eliminate the impact of the Pr55gag variant on Gagp6Pol release, we blocked Pr55gag variant expression by changing the slippery sequence TTT TTA to TTC CTC (hereafter referred to as the fs 2 mutation), thereby disrupting 21 ribosomal frameshift events (Doyon et al., 1998) . Our results indicate that p6gag-containing Gag-Pol molecules were still detectable in medium despite the blocking of this variant (Fig. 1c, upper panel, , suggesting that the release of p6gag-containing Gag-Pol is independent of Pr55gag variants. Unless otherwise indicated, the p6gag-containing Gag-Pol constructs were all expressed in the fs 2 backbone.
To confirm the presence of the recovered p6-containing Gag-Pol constructs, Gag-Pol and Pr55gag pellets were spun together through the same sucrose density gradient.
Results indicate that Gagp6-Pol, Gagp6-PR and Gagp6-RT co-sedimented with WT Pr55gag, and banded in fractions with densities between 1.16 and 1.18 g ml
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( Fig. 2a-c, arrows) , suggesting that p6gag-containing Gag-Pol is capable of egressing into medium in the form of VLPs that possess WT HIV-1 particle densities.
To further confirm that Gagp6-Pol was released in the form of membrane-enveloped particles, sucrose gradient fractions with densities between 1.16 and 1.18 g ml
were collected and observed using transmission electron microscopy. Results indicate that particles formed by Gagp6-Pol were heterogeneous in size compared with WT particles (Fig. 2d, e) . According to thin-section transmission electron micrographs, Gagp6-Pol VLPs did not exhibit the same clear shells that were observed in the WT VLPs (Fig. 2h, arrowheads) , suggesting the aberrant packaging of large Gagp6-Pol molecules.
Inefficient Gagp6-Pol particle processing
Next, we looked at whether VLPs formed by Gag-Pol can be cleaved to produce mature Gag products when a functional PR is provided in trans. Gag-Pol constructs containing p6gag were co-expressed with a PR-expressing Gag-Pol frameshift mutant, D(MA+2/3CA)fs, that has a two-thirds N-terminal Gag deletion, but with a retained N-terminal MA myristylation signal (Chiu et al., 2002) . We therefore determined that detected MA and CA were derived from p6gag-containing Gag-Pol cleavages, but not from autocleavages of the co-expressed D(MA+2/3CA)fs. Since PR expression level can significantly impact virus assembly and release, the amount of co-transfected D(MA+2/ 3CA)fs plasmid DNA was adjusted to between 5 and 10 % that of the p6gag-containg Gag-Pol constructs. When Pr55gag was co-transfected with D(MA+2/3CA)fs at a ratio of 10 : 1, p24gag and p17gag were readily detected in supernatants (Fig. 3a, At 48 h post-transfection, culture supernatants and cells were collected and prepared for protein analysis as described in Methods. Viral pellets (50 % of total sample) and cell lysates (5 % of total sample) were fractionated using 8 % SDS-PAGE and electroblotted onto nitrocellulose filters. HIV-1 Gag proteins were probed with an anti-p24CA mAb. HIV-1 Pr160gag-pol and Pr55gag positions are shown. Asterisks indicate truncated Gag-Pol proteins (approx. 55 kDa, referred to as Pr55gag variants) resulting from translation termination following ribosomal shifts from Gag to Pol reading frames. 'fs 2 ' denotes a mutation that prevents this frameshifting event, which mitigates WT Gag-Pol and mutant Pr55gag variant expression.
cell-associated Gag-Pol can be processed by PR, PR is incapable of efficiently mediating virus-associated GagPol processing. This implies that the aberrant packaging of p6gag-containing Gag-Pol within VLPs may impede PR cleavage accessibility.
Molecular size reduction partly alleviates Gag-Pol release defect
To test whether the Gag-Pol release defect is attributable to large molecular size or specific domain sequences, Pol sequences within GPfsd and Gagp6-Pol were stepwise deleted from the C and N termini (Fig. 4a, c) . Results indicate that Gag-Pol molecule size reduction did improve GagPol release, with release efficiency significantly correlated with the degree of size reduction (Fig. 4b , lanes 7-10).
p6gag-lacking Gag-2561T or Gag-3824T was released at lower efficiency levels compared with their p6gag-containing counterparts (Fig. 4d , upper panel, lanes 2 and 3 versus 7 and 8), but with Gag-3467T still barely detectable in medium despite having a smaller size than Gag-3824T (lane 3 versus lane 4). Likewise, Gagp6-3824T was released more efficiently than Gagp6-3467T (lane 7 versus lane 8). These results suggest that the release defect may be due, at least in part, to a protein conformation restraint.
Release-defective Gag-Pol constructs are efficiently packaged into VLPs
Since all of the Gag-Pol constructs contain the Gag assembly domain, they should be capable of multimerization despite release failure. To test this assumption, Gag-Pol To make direct comparisons with WT particle density, resuspended viral pellets containing Gagp6-Pol, Gagp6-PR or Gagp6-RT were centrifuged with Pr55gag-containing suspensions through the same sucrose density (20-60 %, w/v) gradient. Fractions were collected from top to bottom, measured for sucrose density, and subjected to Western immunoblotting. Pr55gag and p6-containing Gag-Pol banded mostly at fractions with densities of 1.16-1.18 g ml 21 (arrows). (d-j) Electron microscopy images of Gag-Pol VLPs. Culture supernatants collected from D25-(d), Gagp6-Pol-(e) or mock-(f) transfected cells were centrifuged through 20 % sucrose cushions. Pellets were resuspended and centrifuged through 20-60 % (w/v) sucrose density gradients. Fractions with sucrose densities corresponding to WT HIV-1 particle densities (1.16-1.18 g ml
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) were pooled and prepared for electron microscopy analysis. Cells transfected with D25 (g, h) or Gagp6-Pol (i, j) were fixed and prepared for transmission electron microscopy observations as described in Methods.
constructs were co-expressed with Pr55gag. We did not observe negative effects on Gag particle production exerted by the release-defective Gag-Pol constructs, whether or not they contained p6gag. Instead, we noted that Pr55gag coexpression caused Gag-Pol constructs that had been barely detectable to become readily detected in medium (Fig. 5 ). According to these data, release-defective GagPol constructs can still oligomerize, and are incorporated into WT VLPs via Pr55gag association.
Release-defective Gag-Pol constructs exhibit reduced membrane-binding
Since membrane association is essential for HIV-1 assembly and release, we looked for possible correlations between release deficit and membrane-binding deficiency for the Gag-Pol constructs. Gag-Pol constructs that are incapable of associating with lipid-enriched and lighter cell membranes cannot float to the interface between 10 and 65 % (w/v) sucrose. Our results indicate that the releasedefective Gag-Pol constructs contained less than 60 % membrane-associated Gag-Pol. In contrast, release-competent Gag-IN and Gagp6-IN exhibited membrane-binding capacities comparable with that of the WT Gag (Fig. 6) . In some cases (e.g. Gagp6-3467T and Gagp6-3468), significantly higher membrane-binding capacities were exhibited compared with their p6-lacking counterparts. These data suggest a significant correlation between Gag-Pol membrane-binding and release.
Release defect triggered by PTAP mutation can be rescued by NEDD4L overexpression
The p6 PTAP motif has been well documented as an HIV-1 budding motif. We therefore performed tests to determine whether Gag-Pol release capability is PTAP-dependent. Results indicate that p6gag-containing Gag-Pol constructs lacking the PTAP motif were barely detectable in medium, suggesting that the release of p6gag-containing Gag-Pol constructs is PTAP-dependent (Fig. 7) .
Based on a report that NEDD4L overexpression can rescue release-defective HIV-1 Gag mutants (Chung et al., 2008) , we performed tests to determine whether NEDD4L co-expression mitigates the Gag-Pol release defect. We found that barely detectable GPfsd and Gagp6 PTAP -Pol both became readily detectable in medium following NEDD4L co-expression (Fig. 8a, lanes 1 and 2 versus lanes  4 and 5) . The quantity of Gagp6-Pol also noticeably increased following NEDD4L co-expression (Fig. 8a , lane 3 versus lane 6). The NEDD4L enhancement effect was not as strong for Gag-Pol constructs with high release efficiency (e.g. Gagp6-IN, data not shown). We also observed that NEDD4L overexpression reduced Gag-Pol construct expression levels under some conditions. Considering cellular expression level, NEDD4L was capable of rescuing all of the release-defective Gag-Pol constructs except for Gag-3467T (Fig. 8b) .
DISCUSSION
By itself, HIV-1 Gag-Pol is not believed to be capable of assembly and cell release, since embedded PR mediates Gag-Pol cleavage during Gag-Pol oligomerization. Even with PR mutational inactivation, HIV-1 Gag-Pol is still incapable of forming VLPs. Our data confirm that the inability of PR-inactivated Gag-Pol to release from cells is largely due to the lack of a p6gag domain. p6gag placement at the C terminus of Pr160gag-pol (GPfsd) still conferred Gag-Pol release capability (data not shown), suggesting that the p6gag effect on Gag-Pol release is not positiondependent. Although p6gag-containing Gag-Pol can form VLPs, release quantities are substantially smaller than that of Pr55gag. This is not surprising, since natural Pr55gag molecules are thought to assemble more readily than large artificial p6gag-containing Gag-Pol. Support for this assumption comes from the observation that molecule size reduction can significantly enhance the release efficiencies of some Gag-Pol constructs. According to our results, (a) the Gag-Pol budding defect is primarily due to the lack of a p6gag domain, and (b) large molecule size may partly contribute to a Gag-Pol budding restriction. However, given that Gagp6-3824T was released more efficiently than Gagp6-3467T (Fig. 4d) , the release defect may be due, at least in part, to a protein conformation restraint.
Initial HIV-1 Gag-Pol cleavage occurs at p2/NC, resulting in N-terminal p41gag (corresponding to MA-CA-p2) (Pettit et al., 2004) . p41gag was the primary VLP-associated Gag cleavage product observed when p6gag-containing GagPol constructs were co-expressed with the DD(MA+2/ 3CA)fs PR expression vector (Fig. 3) , suggesting that DD(MA+2/3CA)fs is packaged into p6gag-containing Gag-Pol VLPs and provides a functional PR. The barely detectable levels of p17gag and p24gag were likely due, at least in part, to the inaccessibility of the MA/CA cleavage site. It is possible that the assembly of large p6gag-containing Gag-Pol into particles may induce atypical Gag-Pol packaging that conceals Gag cleavage sites. Support for this possibility comes from our observation that Gagp6-Pol VLPs exhibit aberrant morphologies that lack clear electrondense cores.
Using a baculovirus expression system, Royer et al. (1997) created recombinant HIV-1 Gag-Pol constructs containing various lengths of PR-inactivated Pol sequence fused inframe to the C-terminal p6 of Pr55gag; they reported that the constructs were barely detectable in culture supernatants. They also reported that the p6-containing Gag-Pol constructs were capable of trans-dominantly inhibiting Gag particle release. In contrast, most of our Gag-Pol constructs containing p6 were capable of release into medium. We did not see any evidence of p6-containing Gag-Pol constructs impeding the release of Gag particles; instead, both release-competent and release-defective constructs were capable of being efficiently packaged into Gag VLPs (Fig. 5) . These contradictory results may be due to different systems employed in the two studies. Royer et al. created a junction heptapeptide STVSFNF between Pol and C-terminal p6gag while engineering p6-containing Gag-Pol recombinants. It is unknown whether junction heptapeptide STVSFNF affected the assembly and release of the resultant constructs. p6gag late-domain PT/SAP is known to bind with the ESCRT-I component TSG101 and to recruit ESCRT machinery (including ESCRT-III and ESCRT accessory factor Vps4) to mediate virus release from cells (Balasubramaniam & Freed, 2011) . NEDD4L overexpression can enhance HIV-1 release by stimulating Gag association with ESCRT-I, which is independent of the p6gag domain (Chung et al., 2008) . HIV-1 Gag domains responsible for the NEDD4L stimulation effect have been mapped to the C-terminal CA region. However, Gag-3467T fails to respond to a NEDD4L enhancement effect (Fig. 8b) . A defect in trafficking or membrane association may partly account for the failure of Gag-3467T release due to NEDD4L overexpression. Gag-3467T misfolding is unlikely because Gag-3467T can still be packaged into WT Gag VLPs (Fig. 5) . A budding-defective HIV-1 MA mutant (MAD96-120) has also been shown to be incapable of G a g -3 4 6 7 T G a g 3 4 6 7 T G a g p 6 -3 4 6 7 T G a g p 6 -3 4 6 7 T G a g -3 4 6 8 G a g -3 8 6 9
G a g p 6 -3 8 6 9 G a g -I N G a g p 6 -I N G a g p 6 -3 0 8 9 G a g p 6 -3 4 6 8 responding to the NEDD4L effect on VLP release enhancement, despite possessing membrane association and multimerization capability (Sanford et al., 2014) . Thus, both the Gag-3467T and MAD96-120 constructs may impair GagPol or Gag particle budding in a manner that is not complemented by NEDD4L overexpression.
METHODS
Plasmid construction. To construct p6-containg Gag-Pol expression constructs, fragments flanking the 59 ends of p6*PR, PR, or RT and a downstream Eco RV site were generated by a forward primer (p6*PR, 59-CGGGATCCAATTTTTTAGGGAA-39; PR, 59-CGGGAT-CCCTCAGGTCACTCTTTG-39; RT, CAGATTGGTTGCAGGATCC ATTTTCCCA-39) and a reverse primer (59-CCTGTGGAAGCACA-TTGTACT-39) using HIVgpt (Page et al., 1990) as template. Amplified fragments were digested with Bam HI and Eco RV, and ligated into an HIV-1 expression vector Gag2289T that contains a created Bam HI site at the Gag C terminus, yielding Gagp6-Pol, Gagp6-PR and Gagp6-RT (Fig. 1) . Nucleotide sequences at the junction area are: Gagp6-Pol, TCA CGG ATC CAA/TTT TTT AGG GAA; Gagp6-PR, TCA CGG ATC /CCT CAG GTC ACT; Gagp6-RT, TCA CGG ATC CAT TTT/CCC ATT. The Gag2289T was engineered by means of overlap extension PCR using a Bam HI-containing primer (59-TCG-TCACGGATCCGATAG-39).
To block the translation of Pol as a result of gag/pol ribosomal frameshifting, a frameshift minus (fs 2 ) mutation was created by changing the TTT TTA nucleotides at the gag/pol overlap junction into CCC CCG. The primer sequence used for creating the fs 2 mutation is 59-CCAGATCT-TCCCCGCGGGATTAGCCTG-39. This fs 2 mutation would block the 21 ribosomal frameshift and reduce the expression of truncated Gag or GagPol fusion proteins from our engineered construct. To further delete the N-terminal Pol, a Bam HI site was created at HIV-1 nucleotide positions 3089, 3468 and 3869 using a reverse primer 3089, 59-ATGT- 3468, 3869, , and a forward primer 59-GGATTAGATATCAGTACAATG-39. The amplified fragments were digested with Bam HI and Eco RV, and each of the Bam HIEco RV fragments was substituted for the Bgl II-2096 to Eco RV-2979 of G a g p 6 -3 4 6 7 T G a g p 6 -3 4 6 8 G a g p 6 -3 0 8 9 G a g -3 8 6 9 G a g -3 4 6 8 G a g -3 0 8 9 the Gag mutant that contains a Bam HI site at the deleted region (a deletion of nt 831-2084). The resulting constructs were digested with Bam HI and Sal I, and ligated into Gag2289T, yielding Gagp6-3089, Gagp6-3468, Gagp6-3869, or ligated into the fs 2 mutant, which was digested with Bgl II and Sal I, yielding constructs Gag3089, Gag3468, Gag3869 (Fig. 4a) . The IN coding sequence was amplified with forward primer 59-TGCTGGATCCGGAAAGTACTA-39 and reverse primer 59-CCATGTCGACATCCTCATCCT-39. By analogy, the amplified IN fragments were digested with Bam HI and Sal I, and ligated into Gag2289T and the fs 2 mutant, yielding Gagp6-IN and Gag-IN, respectively. Recombination of the C-terminal truncation mutations 4243T, 3824T, 3467T and 2561T (Liao & Wang, 2004) with GPfsd and Gagp6-Pol yielded Gag-4243T, Gag-3824T, Gag-3467T and Gag-2561T, and Gagp6-4243T, Gagp6-3824T, Gagp6-3467T and Gagp6-2561T (Fig.  4c) , respectively.
To construct p6PTAP2, fragments containing PTAP 2 mutation were generated by forward primer 59-CAGACCAGAGCTCATACGCCTA-CCAGAAGAG-39 and reverse primer 59-ACTGGTACAGTCTCAAT-AGGGCTAATG-39. The resulting PCR product was then used as a megaprimer for a second round of PCR, by using forward primer 59-ATGAGAGAACCAAGGGGAAGTGTGA-39. The PCR products were then digested with Spe I and Bcl I, and ligated into the p6gag-containing Gag-Pol constructs. NEDD4L expression vector pCI HA NEDD4L was a gift from Joan Massague, Memorial Sloan Kettering Cancer Center (Gao et al., 2009 ).
Electron microscopy. For transmission electron microscopy analysis, cells were harvested 12 h post-infection, fixed in 0.1 M cacodylate buffer containing 2.5 % glutaraldehyde, post-fixed with 1 % OsO 4 , dehydrated in ethanol and embedded in Spurr resin. Ultrathin sections (*70 nm thick) were cut with an ultramicrotome, stained with 5 % uranyl acetate and 0.4 % lead citrate, and viewed with a Joel JEM-2000 EX-II transmission electron microscope. For visualization of particles isolated from culture supernatants, sucrose density gradient fractions with sucrose densities corresponding to WT Gag particle densities were pooled, mixed with 1| PBS and pelleted. Concentrated viral sample was placed for 2 min onto a carbon-coated, UV-treated 200-mesh copper grid. Sample-containing grids were rinsed for 15 s in water, dried with filter paper, and stained for 1 min in filtered 1.3 % uranyl acetate. Staining solution was removed by applying filter paper to the edge of the grid. Images were collected at|20 000, |60 000 or |100 000 magnification.
Cell culture and transfection. Cells were maintained in DMEM supplemented with 10 % FCS. Confluent 293T cells were trypsinized, split 1 : 10 and seeded onto 10 cm plates 24 h before transfection. For each construct, 293T cells were transfected with 20 mg plasmid DNA by the calcium phosphate precipitation method, with the addition of 50 mm chloroquine to enhance transfection efficiency. At 48-72 h after transfection, supernatants and cells were collected for protein analysis.
Western immunoblot analysis. Culture medium from transfected 293T cells was filtered through 0.45 mm pore-size filters, followed by centrifugation through 2 ml 20 % sucrose in TSE (10 mM Tris/HCl, pH 7.5, 100 mM NaCl, 1 mM EDTA) containing 0.1 mM PMSF at 4 uC for 40 min at 274 000 g (SW41 rotor at 40 000 r.p.m.). The viral pellets were then suspended in IPB buffer (20 mM Tris/HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.1 % SDS, 0.5 % sodium deoxycholate, 1 % Triton X-100, 0.02 % sodium azide) containing 0.1 mM PMSF. The cells were rinsed with ice-cold PBS, scraped from the plates, collected in 1 ml PBS, and pelleted at 940 g for 5 min. The cell pellets were resuspended in 250 ml IPB containing 0.1 mM PMSF, and then subjected to microcentrifugation at 4 uC for 15 min at 13 700 g to remove cell debris. The supernatant and cell samples were mixed with equal volumes of 2| sample buffer (12.5 mM Tris/HCl, pH 6.8, 2 % SDS, 20 % glycerol, 0.25 % bromophenol blue) containing b-mercaptoethanol (5 %), and boiled for 5 min. Samples were subjected to 8 or 10 % SDS-PAGE and electroblotted onto nitrocellulose membranes. Protocols for detection of membrane-bound proteins were as described previously (Chiang et al., 2010) using an enhanced chemiluminescence (ECL) detection system according to the manufacturer's protocol (Pierce). HIV-1 Gag/Gag-Pol or HA-tagged NEDD4L proteins were probed by using an anti-p24gag (mouse hybridoma clone 183-H12-5C) or anti-HA (LTK BioLaboratories) mAb. The secondary antibody was a sheep anti-mouse or donkey anti-rabbit-HRP-conjugated antibody (Invitrogen).
Sucrose density gradient fractionation. Culture supernatants of transfected 293T cells were collected, filtered and centrifuged through a 2 ml 20 % (w/v) sucrose cushion as described above. Viral pellets were suspended in TSE buffer and overlaid on a pre-made 20-60 % (w/v) sucrose gradient consisting of 1 ml layers of 20, 30, 40, 50 and 60 % (w/v) sucrose in TSE buffer, which had been allowed to mix while sitting for 2 h. Gradients were centrifuged at 274 000 g (SW50.1 rotor at 40 000 r.p.m.) for 16 h at 4 uC, and 500 ml fractions were collected from top to bottom. Sucrose density was measured for each of the fractions. Proteins in each of the fractions were precipitated with 10 % trichloroacetic acid, and subjected to Western immunoblotting.
Membrane flotation centrifugation. At 48 h post-transfection, 293T were rinsed twice, pelleted in PBS, and resuspended in TE buffer (10 mM Tris/HCl pH 7.4, 1 mM EDTA) containing 10 % (w/v) sucrose, and cOmplete Protease Inhibitor Cocktail (Roche). Cell suspensions were subjected to sonication followed by low-speed centrifugation. Two hundred microlitres of post-nuclear supernatants were mixed with 1.3 ml 85.5 % (w/v) sucrose in TEN buffer (50 mM G a g p 6 -R T G a g p 6 -P R G a g p 6 -P o l G a g p 6 P TA P -R T G a g p 6 P TA P -P R G a g p 6 P TA P -P o l Fig. 7 . Gag-Pol release is p6 PTAP motif-dependent. 293T cells were transfected with the indicated constructs. At 48 h posttransfection, cells and supernatants were collected and subjected to Western immunoblotting as described in Methods. PTAP
